979P Initial results from the phase II randomized trial comparing TACE with irinotecan and mitomycin C to doxorubicin in intermediate stage HCC (IRITACE trial). - Waidmann, O.; Gruber-Rouh, T.; Koch, C.; Götze, T.O.; Schultheiss, M.; Herrmann, E.; Steup, C.; Trojan, J.; Vogl, T.J.J.; Zeuzem, S.; Finkelmeier, F. (Annals of Oncology, 2024)